Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glabellar Lines”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT07622004
What this trial is testing

Evaluate the Efficacy and Safety of INI101 Compared to BOTOX® in Subjects With Moderate to Severe Glabellar Lines.

Who this might be right for
Glabellar Lines
INIBIO Co., Ltd. 292
Large-scale testing (Phase 3)Study completedNCT02334436
What this trial is testing

A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 324
Large-scale testing (Phase 3)Study completedNCT06583486
What this trial is testing

A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd. 488
Large-scale testing (Phase 3)Study completedNCT06308198
What this trial is testing

Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines

Who this might be right for
Glabellar Lines
AbbVie 161
Testing effectiveness (Phase 2)Study completedNCT02428608
What this trial is testing

Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 570
Post-approval studies (Phase 4)Study completedNCT02096081
What this trial is testing

The Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz North America, Inc. 250
Early research (Phase 1)Study completedNCT06834789
What this trial is testing

Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)

Who this might be right for
Glabellar Lines
AbbVie 132
Early research (Phase 1)Study completedNCT06604832
What this trial is testing

Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture

Who this might be right for
Skin AgingSkin Wrinkling
Kalpna Kay Durairaj, MD, FACS 20
Testing effectiveness (Phase 2)Study completedNCT02961673
What this trial is testing

The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Huons Co., Ltd. 57
Large-scale testing (Phase 3)Study completedNCT01447342
What this trial is testing

Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines

Who this might be right for
Facial WrinklesSkin Aging
Pacira Pharmaceuticals, Inc 54
Large-scale testing (Phase 3)UnknownNCT05801146
What this trial is testing

Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Hugel 272
Testing effectiveness (Phase 2)Study completedNCT06199336
What this trial is testing

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd. 190
Large-scale testing (Phase 3)Study completedNCT02677805
What this trial is testing

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II

Who this might be right for
Glabellar Frown Lines
Croma-Pharma GmbH 251
Large-scale testing (Phase 3)Study completedNCT00777803
What this trial is testing

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 381
Large-scale testing (Phase 3)Study completedNCT06585696
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Who this might be right for
Glabellar Frown Lines
Cutia Therapeutics（Wuxi）Co.,Ltd 554
Very early researchStudy completedNCT05129319
What this trial is testing

Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 30
Large-scale testing (Phase 3)Study completedNCT00694148
What this trial is testing

Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines

Who this might be right for
Healthy
Merz Pharmaceuticals GmbH 108
Large-scale testing (Phase 3)Study completedNCT03908008
What this trial is testing

Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line

Who this might be right for
Glabellar Frown Lines
Medy-Tox 136
Post-approval studies (Phase 4)Study completedNCT01391312
What this trial is testing

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Who this might be right for
Glabellar Frown Lines
Allergan 40
Large-scale testing (Phase 3)UnknownNCT03440671
What this trial is testing

The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Huons Co., Ltd. 260
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation